Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 54.33-44.2617.0052.4650.10

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 54.33 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46
Mar202150.10

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46
4.71
Mar2021 50.1 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,008.6 Cr 1.2% 4% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.2%

4%

43.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses